epitoMAP Inc. and Animal Allergy Clinical Laboratories Inc. entered into a License Agreement for an antibody pharmaceutical for veterinary use, CRE-DR-B, with Nippon Zenyaku Kogyo Co., Ltd.　on November 10, 2023.

https://www.prnewswire.com/news-releases/epitomap-inc-animal-allergy-clinical-laboratories-inc-and-nippon-zenyaku-kogyo-co-ltd-enter-into-license-agreement-301991565.html